Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth R Gerstner

Showing results (71-80 of 133) with videos related to

Pageof 14
Sort By:
Neuro-Oncology|May 27, 2015
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastomaElizabeth R Gerstner, Xiaobu Ye, Dan G Duda, et al.
Neuro-Oncology Advances|September 8, 2022
Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastomaMohamed E El-Abtah, Pratik Talati, Melanie Fu, et al.
Neuro-Oncology|June 26, 2021
SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumorsTobias Walbert, Rebecca A Harrison, David Schiff, et al.
Neuro-Oncology Advances|January 4, 2021
Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patientsElizabeth R Gerstner, Kyrre E Emblem, Yi-Fen Yen, et al.
Academic Radiology|November 11, 2023
Not without Context-A Multiple Methods Study on Evaluation and Correction of Automated Brain Tumor Segmentations by ExpertsKatharina V Hoebel, Christopher P Bridge, Albert Kim, et al.
Magnetic Resonance Imaging|August 18, 2012
Promise and pitfalls of quantitative imaging in oncology clinical trialsBrenda F Kurland, Elizabeth R Gerstner, James M Mountz, et al.
Cancer|December 22, 2017
Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastomaDavid A Reardon, Andrew B Lassman, David Schiff, et al.
Blood|July 2, 2008
CNS Hodgkin lymphomaElizabeth R Gerstner, Lauren E Abrey, David Schiff, et al.
Plos One|June 15, 2018
ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopyEva-Maria Ratai, Zheng Zhang, James Fink, et al.
Nature Communications|April 18, 2018
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarateOvidiu C Andronesi, Isabel C Arrillaga-Romany, K Ina Ly, et al.
Pageof 14

Showing results (71-80 of 133) with videos related to

Sort By:
Pageof 14
Neuro-Oncology|May 27, 2015
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastomaElizabeth R Gerstner, Xiaobu Ye, Dan G Duda, et al.
Neuro-Oncology Advances|September 8, 2022
Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastomaMohamed E El-Abtah, Pratik Talati, Melanie Fu, et al.
Neuro-Oncology|June 26, 2021
SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumorsTobias Walbert, Rebecca A Harrison, David Schiff, et al.
Neuro-Oncology Advances|January 4, 2021
Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patientsElizabeth R Gerstner, Kyrre E Emblem, Yi-Fen Yen, et al.
Academic Radiology|November 11, 2023
Not without Context-A Multiple Methods Study on Evaluation and Correction of Automated Brain Tumor Segmentations by ExpertsKatharina V Hoebel, Christopher P Bridge, Albert Kim, et al.
Magnetic Resonance Imaging|August 18, 2012
Promise and pitfalls of quantitative imaging in oncology clinical trialsBrenda F Kurland, Elizabeth R Gerstner, James M Mountz, et al.
Cancer|December 22, 2017
Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastomaDavid A Reardon, Andrew B Lassman, David Schiff, et al.
Blood|July 2, 2008
CNS Hodgkin lymphomaElizabeth R Gerstner, Lauren E Abrey, David Schiff, et al.
Plos One|June 15, 2018
ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopyEva-Maria Ratai, Zheng Zhang, James Fink, et al.
Nature Communications|April 18, 2018
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarateOvidiu C Andronesi, Isabel C Arrillaga-Romany, K Ina Ly, et al.
Pageof 14